Intake of the Total, Classes, and Subclasses of (Poly)Phenols and Risk of Prostate Cancer: A Prospective Analysis of the EPIC Study

Author:

Almanza-Aguilera Enrique1ORCID,Guiñón-Fort Daniel1,Perez-Cornago Aurora2,Martínez-Huélamo Miriam34ORCID,Andrés-Lacueva Cristina34ORCID,Tjønneland Anne56ORCID,Eriksen Anne Kirstine5,Katzke Verena7,Bajracharya Rashmita7ORCID,Schulze Matthias B.89ORCID,Masala Giovanna10ORCID,Oliverio Andreina11ORCID,Tumino Rosario12ORCID,Manfredi Luca13,Lasheras Cristina14,Crous-Bou Marta1,Sánchez Maria-José15161718ORCID,Amiano Pilar171920,Colorado-Yohar Sandra M.172122ORCID,Guevara Marcela172324ORCID,Sonestedt Emily25ORCID,Bjartell Anders26,Thysell Elin27,Weiderpass Elisabete28,Aune Dagfinn293031ORCID,Aglago Elom K.29ORCID,Travis Ruth C.2,Zamora-Ros Raul1ORCID

Affiliation:

1. Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain

2. Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK

3. Biomarkers and Nutrimetabolomics Laboratory, Department of Nutrition, Food Sciences and Gastronomy, Nutrition and Food Safety Research Institute (INSA), Food Innovation Network (XIA), Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain

4. Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, 28029 Madrid, Spain

5. Danish Cancer Society Research Center, Danish Cancer Society, 2100 Copenhagen, Denmark

6. Department of Public Health, University of Copenhagen, 2177 Copenhagen, Denmark

7. Department of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany

8. Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, 14558 Nuthetal, Germany

9. Institute of Nutritional Science, University of Potsdam, 14558 Nuthetal, Germany

10. Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network—ISPRO, 50139 Florence, Italy

11. Epidemiology and Prevention Unit, Department of Epidemiology and Data Science, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milan, Italy

12. Hyblean Association for Epidemiological Research (AIRE-ONLUS), 97100 Ragusa, Italy

13. Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy

14. Functional Biology Department, University of Oviedo, 33003 Oviedo, Spain

15. Granada Cancer Registry, Andalusian School of Public Health (EASP), Instituto de Investigación Biosanitaria Ibs. GRANADA, University of Granada, 18011 Granada, Spain

16. Instituto de Investigación Biosanitaria Ibs. GRANADA, 18012 Granada, Spain

17. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain

18. Department of Preventive Medicine and Public Health, University of Granada, 18071 Granada, Spain

19. Ministry of Health of the Basque Government, Sub Directorate for Public Health and Addictions of Gipuzkoa, 20013 San Sebastian, Spain

20. Epidemiology of Chronic and Communicable Diseases Group, BioGipuzkoa Health Research Institute, 20014 San Sebastian, Spain

21. Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia University, 30003 Murcia, Spain

22. Research Group on Demography and Health, National Faculty of Public Health, University of Antioquia, Medellín 050010, Colombia

23. Navarra Public Health Institute, 31003 Pamplona, Spain

24. Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain

25. Nutritional Epidemiology, Department of Clinical Sciences Malmö, Lund University, 214 28 Malmö, Sweden

26. Department of Urology, Skåne University Hospital, 205 02 Malmö, Sweden

27. Department of Medical Biosciences, Umeå University, 901 87 Umeå, Sweden

28. International Agency for Research on Cancer (IARC/WHO), 69372 Lyon, France

29. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, UK

30. Department of Nutrition, Oslo New University College, 0456 Oslo, Norway

31. Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, 0424 Oslo, Norway

Abstract

Existing epidemiological evidence regarding the potential role of (poly)phenol intake in prostate cancer (PCa) risk is scarce and, in the case of flavonoids, it has been suggested that their intake may increase PCa risk. We investigated the associations between the intake of the total and individual classes and subclasses of (poly)phenols and the risk of PCa, including clinically relevant subtypes. The European Prospective Investigation into Cancer and Nutrition (EPIC) cohort included 131,425 adult men from seven European countries. (Poly)phenol intake at baseline was assessed by combining validated center/country-specific dietary questionnaires and the Phenol-Explorer database. Multivariable-adjusted Cox proportional hazards models were used to estimate the hazard ratios (HR) and 95% confidence intervals (CI). In total, 6939 incident PCa cases (including 3501 low-grade and 710 high-grade, 2446 localized and 1268 advanced, and 914 fatal Pca cases) were identified during a mean follow-up of 14 years. No associations were observed between the total intake of (poly)phenols and the risk of PCa, either overall (HRlog2 = 0.99, 95% CI 0.94–1.04) or according to PCa subtype. Null associations were also found between all classes (phenolic acids, flavonoids, lignans, and stilbenes) and subclasses of (poly)phenol intake and the risk of PCa, overall and according to PCa subtype. The results of the current large prospective cohort study do not support any association between (poly)phenol intake and PCa incidence.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference49 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021

2. Modifiable Risk Factors for Prostate Cancer in Low- and Lower-Middle-Income Countries: A Systematic Review and a Meta-Analysis;Cirne;Prostate Cancer Prostatic Dis.,2022

3. Epidemiology and Prevention of Prostate Cancer;Gandaglia;Eur. Urol. Oncol.,2021

4. The Epidemiology of Prostate Cancer;Pernar;Cold Spring Harb. Perspect. Med.,2018

5. Wild, C.P., Weiderpass, E., and Stewart, B.W. (2020). World Cancer Report: Cancer Research for Cancer Prevention.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Natural products targeting the MAPK-signaling pathway in cancer: overview;Journal of Cancer Research and Clinical Oncology;2024-01-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3